X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs PFIZER - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD PFIZER ALEMBIC LTD/
PFIZER
 
P/E (TTM) x 121.8 31.0 393.1% View Chart
P/BV x 4.5 4.9 91.8% View Chart
Dividend Yield % 0.2 0.7 37.7%  

Financials

 ALEMBIC LTD   PFIZER
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
PFIZER
Mar-16
ALEMBIC LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs532,724 1.9%   
Low Rs291,611 1.8%   
Sales per share (Unadj.) Rs4.7440.9 1.1%  
Earnings per share (Unadj.) Rs8.848.7 18.0%  
Cash flow per share (Unadj.) Rs9.075.8 11.9%  
Dividends per share (Unadj.) Rs0.1515.00 1.0%  
Dividend yield (eoy) %0.40.7 52.8%  
Book value per share (Unadj.) Rs27.7462.9 6.0%  
Shares outstanding (eoy) m267.0345.75 583.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.74.9 176.9%   
Avg P/E ratio x4.744.5 10.5%  
P/CF ratio (eoy) x4.628.6 15.9%  
Price / Book Value ratio x1.54.7 31.6%  
Dividend payout %1.730.8 5.6%   
Avg Mkt Cap Rs m10,96299,163 11.1%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m2382,758 8.6%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m1,26020,170 6.2%  
Other income Rs m264857 30.8%   
Total revenues Rs m1,52421,028 7.2%   
Gross profit Rs m834,310 1.9%  
Depreciation Rs m611,239 5.0%   
Interest Rs m05 5.8%   
Profit before tax Rs m2853,923 7.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-3299 -32.6%   
Tax Rs m61,794 0.3%   
Profit after tax Rs m2,3432,228 105.2%  
Gross profit margin %6.621.4 30.7%  
Effective tax rate %2.145.7 4.7%   
Net profit margin %185.911.0 1,683.1%  
BALANCE SHEET DATA
Current assets Rs m1,68916,299 10.4%   
Current liabilities Rs m4867,594 6.4%   
Net working cap to sales %95.443.2 221.1%  
Current ratio x3.52.1 161.8%  
Inventory Days Days21765 332.3%  
Debtors Days Days8126 314.7%  
Net fixed assets Rs m1,6248,622 18.8%   
Share capital Rs m534458 116.7%   
"Free" reserves Rs m5,96020,722 28.8%   
Net worth Rs m7,40421,180 35.0%   
Long term debt Rs m10425 417.2%   
Total assets Rs m8,01029,137 27.5%  
Interest coverage x950.7755.5 125.8%   
Debt to equity ratio x00 1,193.5%  
Sales to assets ratio x0.20.7 22.7%   
Return on assets %29.37.7 381.7%  
Return on equity %31.610.5 300.8%  
Return on capital %31.319.0 164.7%  
Exports to sales %2.90.1 4,948.0%   
Imports to sales %28.917.5 165.1%   
Exports (fob) Rs m3712 309.2%   
Imports (cif) Rs m3643,526 10.3%   
Fx inflow Rs m3752 71.8%   
Fx outflow Rs m365140 260.7%   
Net fx Rs m-328-88 371.2%   
CASH FLOW
From Operations Rs m3463,436 10.1%  
From Investments Rs m-48-6,991 0.7%  
From Financial Activity Rs m-301-619 48.6%  
Net Cashflow Rs m-3-4,174 0.1%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.2 7.5 2.7%  
FIIs % 9.7 4.9 198.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 23.7 110.1%  
Shareholders   54,701 85,207 64.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 19, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS